Steven Law

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

David Adams, Michael Polydefkis, Alejandra González‐Duarte et al. · The Lancet Neurology · 2020 · 156 citations

Medicine, Neurology, Pharmacotherapy +14

Conventional heart failure therapy in cardiac ATTR amyloidosis

Adam Ioannou, Paolo Massa, Rishi Patel et al. · European Heart Journal · 2023 · 137 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +16

Longitudinal strain is an independent predictor of survival and response to therapy in patients with systemic AL amyloidosis

Oliver Cohen, Andreia Ismael, Babita Pawarova et al. · European Heart Journal · 2021 · 110 citations · Full text

Medicine, Internal Medicine, Systemic Pathology +4

Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment

Ana Martinez–Naharro, Rishi Patel, Tushar Kotecha et al. · European Heart Journal · 2022 · 108 citations · Full text

Medicine, Hematology, Oncology +17

Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis

Muhammad U. Rauf, Philip N. Hawkins, Francesco Cappelli et al. · European Heart Journal · 2023 · 96 citations · Full text

Medicine, Cardiology, Nuclear Medicine +14